# Farmland Partners Inc.: financial statements, quarterly FPI · NYSE · CIK 1591670 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/fpi.md) · [Financials](/companies/fpi/financials.md) · [Filings](/companies/fpi/filings.md) · [Insiders](/companies/fpi/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fpi/financials.md?period=annual). ## Income statement | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [21.6](/filings/0001558370-25-001214.md) | [12.0](/filings/0001558370-25-006962.md) | [11.4](/filings/0001558370-25-009534.md) | [13.3](/filings/0001104659-25-104363.md) | [21.5](/filings/0001558370-25-001214.md) | [10.3](/filings/0001104659-26-052874.md) | [10.0](/filings/0001104659-26-088677.md) | [11.3](/filings/0001104659-26-120201.md) | [20.7 d](/filings/0001104659-26-017533.md) | [10.1](/filings/0001104659-26-052874.md) | [9.4](/filings/0001104659-26-088677.md) | [9.8](/filings/0001104659-26-120201.md) | | Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Interest expense | $m | [5.7 d](/filings/0001558370-24-002182.md) | [5.0](/filings/0001558370-24-006380.md) | [5.2](/filings/0001558370-25-009534.md) | [5.5](/filings/0001104659-25-104363.md) | [3.1 d](/filings/0001104659-26-017533.md) | [2.6](/filings/0001104659-26-052874.md) | [2.4](/filings/0001104659-26-088677.md) | [2.3](/filings/0001104659-26-120201.md) | [2.3 d](/filings/0001104659-26-017533.md) | [2.7](/filings/0001104659-26-052874.md) | [3.1](/filings/0001104659-26-088677.md) | [3.2](/filings/0001104659-26-120201.md) | | Income tax | $m | [0.0](/filings/0001558370-25-001214.md) | [0.0](/filings/0001558370-25-006962.md) | [(0.0)](/filings/0001558370-25-009534.md) | [0.0](/filings/0001104659-25-104363.md) | [(0.0)](/filings/0001558370-25-001214.md) | [0.0](/filings/0001104659-26-052874.md) | [(0.0)](/filings/0001104659-26-088677.md) | [(0.0)](/filings/0001104659-26-120201.md) | [(0.0) d](/filings/0001104659-26-017533.md) | [0.0](/filings/0001104659-26-052874.md) | [0.0](/filings/0001104659-26-088677.md) | [(0.0)](/filings/0001104659-26-120201.md) | | Net income | $m | [17.8](/filings/0001558370-25-001214.md) | [1.4](/filings/0001558370-25-006962.md) | [(2.0)](/filings/0001558370-25-009534.md) | [1.8](/filings/0001104659-25-104363.md) | [60.3](/filings/0001558370-25-001214.md) | [2.0](/filings/0001104659-26-052874.md) | [7.6](/filings/0001104659-26-088677.md) | [0.5](/filings/0001104659-26-120201.md) | [21.4 d](/filings/0001104659-26-017533.md) | [0.6](/filings/0001104659-26-052874.md) | [3.1](/filings/0001104659-26-088677.md) | [(15.4)](/filings/0001104659-26-120201.md) | | Diluted EPS | $ per share | [0.30](/filings/0001558370-25-001214.md) | [0.01](/filings/0001558370-25-006962.md) | [(0.06)](/filings/0001558370-25-009534.md) | [0.02](/filings/0001104659-25-104363.md) | [1.04](/filings/0001558370-25-001214.md) | [0.03](/filings/0001104659-26-052874.md) | [0.14](/filings/0001104659-26-088677.md) | [0.00](/filings/0001104659-26-120201.md) | not reported | [0.01](/filings/0001104659-26-052874.md) | [0.07](/filings/0001104659-26-088677.md) | [(0.36)](/filings/0001104659-26-120201.md) | | Basic EPS | $ per share | [0.35](/filings/0001558370-25-001214.md) | [0.01](/filings/0001558370-25-006962.md) | [(0.06)](/filings/0001558370-25-009534.md) | [0.02](/filings/0001104659-25-104363.md) | [1.22](/filings/0001558370-25-001214.md) | [0.03](/filings/0001104659-26-052874.md) | [0.15](/filings/0001104659-26-088677.md) | [0.00](/filings/0001104659-26-120201.md) | not reported | [0.01](/filings/0001104659-26-052874.md) | [0.07](/filings/0001104659-26-088677.md) | [(0.36)](/filings/0001104659-26-120201.md) | - Revenue: us-gaap:Revenues - Operating income: not reported - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Total assets | $m | [1,022](/filings/0001558370-25-001214.md) | [1,031](/filings/0001558370-24-006380.md) | [1,028](/filings/0001558370-24-010177.md) | [1,027](/filings/0001558370-24-014053.md) | [870](/filings/0001104659-26-017533.md) | [810](/filings/0001558370-25-006962.md) | [777](/filings/0001558370-25-009534.md) | [739](/filings/0001104659-25-104363.md) | [719](/filings/0001104659-26-120201.md) | [712](/filings/0001104659-26-052874.md) | [700](/filings/0001104659-26-088677.md) | [681](/filings/0001104659-26-120201.md) | | Total liabilities | $m | [391](/filings/0001558370-25-001214.md) | [405](/filings/0001558370-24-006380.md) | [407](/filings/0001558370-24-010177.md) | [406](/filings/0001558370-24-014053.md) | [273](/filings/0001104659-26-017533.md) | [219](/filings/0001558370-25-006962.md) | [203](/filings/0001558370-25-009534.md) | [180](/filings/0001104659-25-104363.md) | [181](/filings/0001104659-26-120201.md) | [248](/filings/0001104659-26-052874.md) | [237](/filings/0001104659-26-088677.md) | [254](/filings/0001104659-26-120201.md) | | Long-term debt | $m | [363](/filings/0001558370-24-002182.md) | [383](/filings/0001558370-24-006380.md) | [393](/filings/0001558370-24-010177.md) | [394](/filings/0001558370-24-014053.md) | [205](/filings/0001558370-25-001214.md) | [203](/filings/0001558370-25-006962.md) | [193](/filings/0001558370-25-009534.md) | [170](/filings/0001104659-25-104363.md) | [162](/filings/0001104659-26-017533.md) | [233](/filings/0001104659-26-052874.md) | [225](/filings/0001104659-26-088677.md) | [240](/filings/0001104659-26-120201.md) | | Shareholders' equity | $m | [529](/filings/0001104659-26-017533.md) | [527](/filings/0001104659-25-104363.md) | [521](/filings/0001104659-25-104363.md) | [519](/filings/0001104659-25-104363.md) | [495](/filings/0001104659-26-120201.md) | [492](/filings/0001104659-26-120201.md) | [474](/filings/0001104659-26-120201.md) | [457](/filings/0001104659-26-120201.md) | [467](/filings/0001104659-26-120201.md) | [464](/filings/0001104659-26-120201.md) | [463](/filings/0001104659-26-120201.md) | [427](/filings/0001104659-26-120201.md) | - Cash and equivalents: not reported - Total assets: us-gaap:Assets - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt - Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ## Cash flow | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [7.2 d](/filings/0001558370-25-001214.md) | [11.9](/filings/0001558370-25-006962.md) | [(6.1) d](/filings/0001558370-25-009534.md) | [(4.3) d](/filings/0001104659-25-104363.md) | [14.6 d](/filings/0001104659-26-017533.md) | [6.4](/filings/0001104659-26-052874.md) | [(2.2) d](/filings/0001104659-26-088677.md) | [(2.0) d](/filings/0001104659-26-120201.md) | [15.2 d](/filings/0001104659-26-017533.md) | [8.2](/filings/0001104659-26-052874.md) | [(3.1) d](/filings/0001104659-26-088677.md) | [(2.3) d](/filings/0001104659-26-120201.md) | | Dividends paid | $m | [2.9 d](/filings/0001558370-25-001214.md) | [13.0](/filings/0001558370-25-006962.md) | [2.9 d](/filings/0001558370-25-009534.md) | [2.9 d](/filings/0001104659-25-104363.md) | [2.9 d](/filings/0001104659-26-017533.md) | [55.7](/filings/0001104659-26-052874.md) | [2.8 d](/filings/0001104659-26-088677.md) | [2.7 d](/filings/0001104659-26-120201.md) | [2.6 d](/filings/0001104659-26-017533.md) | [11.2](/filings/0001104659-26-052874.md) | [3.9 d](/filings/0001104659-26-088677.md) | [3.9 d](/filings/0001104659-26-120201.md) | | Share repurchases | $m | [3.7 d](/filings/0001558370-25-001214.md) | not reported | not reported | not reported | not reported | [0.7](/filings/0001104659-26-052874.md) | [23.5 d](/filings/0001104659-26-088677.md) | [13.6 d](/filings/0001104659-26-120201.md) | [0.0 d](/filings/0001104659-26-017533.md) | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [48.4](/filings/0001558370-25-001214.md) | [55.6](/filings/0001558370-25-001214.md) | [47.7](/filings/0001558370-25-006962.md) | [47.8](/filings/0001558370-25-009534.md) | [47.8](/filings/0001104659-25-104363.md) | [55.1](/filings/0001558370-25-001214.md) | [45.6](/filings/0001104659-26-052874.md) | [54.0](/filings/0001104659-26-088677.md) | [43.2](/filings/0001104659-26-120201.md) | [43.2](/filings/0001104659-26-052874.md) | [43.4](/filings/0001104659-26-088677.md) | [42.9](/filings/0001104659-26-120201.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 41,978,212 at 2026-10-23, from the cover of the [10-Q filed 2026-10-29](/filings/0001104659-26-120201.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 17:36 ET. No prices; not investment advice.